# Geropharm clinical trials: 23 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Geropharm as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Geropharm: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/geropharm

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 17, 2025 | NCT07070752 | Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients | Geropharm | Phase 3 | Completed | Type 1 Diabetes Mellitis | 224 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07070752) |
| July 11, 2024 | NCT06497049 | Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. | Geropharm | Phase 1 | Completed | Pharmacokinetics, Safety Issues, Bioequivalence | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06497049) |
| July 11, 2024 | NCT06497036 | Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia | Geropharm | Phase 3 | Active not recruiting | Drug Effect, Safety Issues, Immunogenicity | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06497036) |
| September 22, 2023 | NCT06050343 | Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method | Geropharm | Not applicable | Completed | Bioequivalence, Therapeutic Equivalency | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06050343) |
| December 15, 2022 | NCT05652595 | Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141 | Geropharm | Phase 1 | Unknown | Pharmacodynamics, Pharmacokinetics, Bioequivalence | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05652595) |
| December 13, 2022 | NCT05648799 | Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) | Geropharm | Not applicable | Completed | Pharmacokinetics, Safety Issues, Efficacy | 246 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05648799) |
| August 6, 2020 | NCT04501250 | Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH... | Geropharm | Not applicable | Completed | Pharmacokinetics, Bioequivalence | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04501250) |
| August 5, 2020 | NCT04498884 | Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC... | Geropharm | Not applicable | Completed | Bioequivalence | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04498884) |
| February 13, 2020 | NCT04268472 | Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia) | Geropharm | Not applicable | Completed | Bioequivalence | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04268472) |
| January 13, 2020 | NCT04226105 | Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients | Geropharm | Phase 3 | Unknown | Diabetes Mellitus, Type 2, Diabetes Mellitus | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04226105) |
| December 3, 2019 | NCT04184492 | A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects | Geropharm | Not applicable | Completed | Clamp Study | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04184492) |
| December 3, 2019 | NCT04184466 | A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects | Geropharm | Not applicable | Completed | Clamp Study | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04184466) |
| September 24, 2019 | NCT04101383 | A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients | Geropharm | Not applicable | Completed | Clamp Study | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04101383) |
| September 24, 2019 | NCT04101370 | Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects | Geropharm | Phase 1 | Completed | Bioequivalence | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04101370) |
| September 6, 2019 | NCT04079413 | Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients | Geropharm | Phase 3 | Completed | Diabetes, Diabetes Mellitus, Type 1 | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04079413) |
| July 17, 2019 | NCT04023344 | Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients | Geropharm | Phase 3 | Completed | Diabetes Mellitus, Type 2, Diabetes Mellitus | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04023344) |
| July 17, 2019 | NCT04022993 | Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients | Geropharm | Phase 3 | Completed | Diabetes Mellitus, Type 1, Diabetes Mellitus | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04022993) |
| July 9, 2019 | NCT04012775 | Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients | Geropharm | Phase 3 | Completed | Diabetes Mellitus, Type 2 | 201 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04012775) |
| July 30, 2018 | NCT03606018 | A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects | Geropharm | Not applicable | Completed | Clamp Study | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03606018) |
| July 27, 2018 | NCT03604575 | A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects | Geropharm | Not applicable | Completed | Clamp Study | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03604575) |
| March 8, 2018 | NCT03458208 | Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects | Geropharm | Phase 1 | Completed | Bioequivalence | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03458208) |
| March 2, 2018 | NCT03452306 | Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and... | Geropharm | Phase 1 | Completed | Bioequivalence | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03452306) |
| April 20, 2017 | NCT03121820 | Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects | Geropharm | Phase 1 | Completed | Bioequivalence, AUC, Cmax, Pharmacokinetics | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03121820) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 3 | 7 |
| Not applicable | 10 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Unknown | 2 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus | 5 |
| Insulin Resistance | 4 |
| Fasting | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetes Mellitus, Type 1 | 2 |
| Lecithin Cholesterol Acyltransferase Deficiency | 2 |
| COVID-19 | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B power plants and power plant companies in the United States](https://specstream.ai/data/businesses/b2b-power-plants-and-power-plant-companies/united-states)
- [Asian fusion restaurants in the United States](https://specstream.ai/data/businesses/asian-fusion-restaurants/united-states)
- [Acoustical consultants in the United States](https://specstream.ai/data/businesses/acoustical-consultants/united-states)
- [Vocational and technical schools in the United States](https://specstream.ai/data/businesses/vocational-and-technical-schools/united-states)
- [Towing companies in the United States](https://specstream.ai/data/businesses/towing-companies/united-states)
- [Stone suppliers in the United States](https://specstream.ai/data/businesses/stone-suppliers/united-states)
